Article Information
History
- October 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthew F. Wipperman*,†,1,2,
- Allen Z. Lin†,3,
- Kaitlyn M. Gayvert†,3,
- Benjamin Lahner1,2,3,
- Selin Somersan-Karakaya2,
- Xuefang Wu4,
- Joseph Im4,
- Minji Lee3,
- Bharatkumar Koyani4,
- Ian Setliff3,
- Malika Thakur4,
- Daoyu Duan1,2,
- Aurora Breazna5,
- Fang Wang1,2,
- Wei Keat Lim3,
- Gabor Halasz3,
- Jacek Urbanek5,
- Yamini Patel6,
- Gurinder S. Atwal3,
- Jennifer D. Hamilton1,2,
- Clotilde Huyghues-Despointes7,
- Oren Levy2,
- Andreja Avbersek2,
- Rinol Alaj*,4,
- Sara C. Hamon*,1,2 and
- Olivier Harari*,2
- 1Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA
- 2Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA
- 3Molecular Profiling & Data Science. Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA
- 4Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA
- 5Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA
- 6General Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA
- 7Medical Affairs, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA
- ↵*Correspondence to:
Matthew.Wipperman{at}regeneron.com; Rinol.Alaj{at}regeneron.com; Sara.Hamon{at}regeneron.com; Olivier.Harari{at}regeneron.com
↵† These authors contributed equally